PortfoliosLab logoPortfoliosLab logo
APYX vs. ENIC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

APYX vs. ENIC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Apyx Medical Corporation (APYX) and Enel Chile S.A. (ENIC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, APYX achieves a 17.14% return, which is significantly higher than ENIC's 15.46% return.


APYX

1D
-0.49%
1M
-4.65%
6M
1.99%
YTD
17.14%
1Y
134.29%
3Y*
-9.49%
5Y*
-14.55%
10Y*
ALL TIME*
-8.39%

ENIC

1D
-2.42%
1M
0.68%
6M
5.98%
YTD
15.46%
1Y
45.96%
3Y*
16.01%
5Y*
18.66%
10Y*
3.28%
ALL TIME*
1.92%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$248.17K$250.43K$617.49K
$2.48M$2.37M$2.61M

APYX vs. ENIC - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
APYX
Apyx Medical Corporation
17.14%121.52%-39.69%11.97%-81.75%78.06%-14.89%6.28%
ENIC
Enel Chile S.A.
15.46%48.47%-3.58%62.00%26.20%-49.96%-12.51%0.87%

Correlation

The correlation between APYX and ENIC is 0.17, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.17

Correlation (3Y)
Balances recent behavior with more history.

0.11

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.14

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2019

0.15

Fundamentals

Market Cap

APYX:

$172.65M

ENIC:

$6.14B

EPS

APYX:

-$0.33

ENIC:

$0.41

PS Ratio

APYX:

2.03

ENIC:

1.41

Total Revenue (TTM)

APYX:

$55.83M

ENIC:

$4.35B

Gross Profit (TTM)

APYX:

$21.29M

ENIC:

$1.13B

EBITDA (TTM)

APYX:

-$3.18M

ENIC:

$1.32B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

APYX vs. ENIC — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

APYX
APYX Risk / Return Rank: 8585
Overall Rank
APYX Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
APYX Sortino Ratio Rank: 8686
Sortino Ratio Rank
APYX Omega Ratio Rank: 8181
Omega Ratio Rank
APYX Calmar Ratio Rank: 8888
Calmar Ratio Rank
APYX Martin Ratio Rank: 8888
Martin Ratio Rank

ENIC
ENIC Risk / Return Rank: 8686
Overall Rank
ENIC Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
ENIC Sortino Ratio Rank: 8383
Sortino Ratio Rank
ENIC Omega Ratio Rank: 8383
Omega Ratio Rank
ENIC Calmar Ratio Rank: 8787
Calmar Ratio Rank
ENIC Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

APYX vs. ENIC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Apyx Medical Corporation (APYX) and Enel Chile S.A. (ENIC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


APYXENICDifference
Sharpe ratioReturn per unit of total volatility

-0.21

Sortino ratioReturn per unit of downside risk

+0.18

Omega ratioGain probability vs. loss probability

1.27

1.29

-0.02

Calmar ratioReturn relative to maximum drawdown

3.15

3.01

+0.14

Martin ratioReturn relative to average drawdown

8.56

9.02

-0.47

APYX vs. ENIC - Sharpe Ratio Comparison

The current APYX Sharpe Ratio is 1.44, which is comparable to the ENIC Sharpe Ratio of 1.65. The chart below compares the historical Sharpe Ratios of APYX and ENIC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

APYX vs. ENIC - Drawdown Comparison

The maximum APYX drawdown since its inception was -94.99%, which is greater than ENIC's maximum drawdown of -79.74%. Use the drawdown chart below to compare losses from any high point for APYX and ENIC.


Loading charts...

Drawdown Indicators


APYXENICDifference

Max Drawdown

Largest peak-to-trough decline

-94.99%

-79.74%

-15.25%

Max Drawdown (1Y)

Largest decline over 1 year

-36.59%

-15.33%

-21.26%

Max Drawdown (3Y)

Largest decline over 3 years

-83.52%

-22.50%

-61.02%

Max Drawdown (5Y)

Largest decline over 5 years

-94.99%

-60.01%

-34.98%

Max Drawdown (10Y)

Largest decline over 10 years

-79.74%

Current Drawdown

Current decline from peak

-76.44%

-4.72%

-71.72%

Average Drawdown

Average peak-to-trough decline

-57.33%

-29.09%

-28.24%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.46%

5.11%

+8.35%

Volatility

APYX vs. ENIC - Volatility Comparison

Apyx Medical Corporation (APYX) has a higher volatility of 17.96% compared to Enel Chile S.A. (ENIC) at 7.05%. This indicates that APYX's price experiences larger fluctuations and is considered to be riskier than ENIC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


APYXENICDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.96%

7.05%

+10.91%

Volatility (6M)

Calculated over the trailing 6-month period

55.31%

22.69%

+32.62%

Volatility (1Y)

Calculated over the trailing 1-year period

80.07%

28.09%

+51.98%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

100.64%

38.03%

+62.61%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

92.69%

35.80%

+56.89%

Dividends

APYX vs. ENIC - Dividend Comparison

APYX has not paid dividends to shareholders, while ENIC's dividend yield for the trailing twelve months is around 4.39%.


PositionTTM2025202420232022202120202019201820172016
APYX
Apyx Medical Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ENIC
Enel Chile S.A.
4.39%5.56%8.55%10.38%1.00%12.08%6.54%4.88%4.97%2.76%2.46%

Financials

APYX vs. ENIC - Financials Comparison

This section allows you to compare key financial metrics between Apyx Medical Corporation and Enel Chile S.A.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

APYX vs. ENIC - Profitability Comparison

The chart below illustrates the profitability comparison between Apyx Medical Corporation and Enel Chile S.A. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

APYX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Apyx Medical Corporation reported a gross profit of 7.93M and revenue of 12.42M. Therefore, the gross margin over that period was 63.8%.

ENIC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Enel Chile S.A. reported a gross profit of 356.99M and revenue of 1.04B. Therefore, the gross margin over that period was 34.2%.

APYX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Apyx Medical Corporation reported an operating income of -911.00K and revenue of 12.42M, resulting in an operating margin of -7.3%.

ENIC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Enel Chile S.A. reported an operating income of 162.17M and revenue of 1.04B, resulting in an operating margin of 15.6%.

APYX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Apyx Medical Corporation reported a net income of -2.11M and revenue of 12.42M, resulting in a net margin of -17.0%.

ENIC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Enel Chile S.A. reported a net income of 109.56M and revenue of 1.04B, resulting in a net margin of 10.5%.


Frequently Asked Questions


APYX and ENIC have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

APYX has higher volatility (17.96%) compared to ENIC (7.05%). In terms of maximum drawdown, APYX dropped -94.99% vs ENIC's -79.74%.

ENIC currently has the higher Sharpe Ratio (1.65 vs 1.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for APYX and ENIC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer